McAdam LLC
XBI icon

McAdam LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

McAdam LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$252K Buy
1,595
+10
+0.6% +$1.58K 0.01% 432
2026
Q2 		$251K Sell
1,585
-29
-2% -$3.92K 0.01% 428
2026
Q1 		$206K Buy
+1,614
New +$201K 0.01% 406
2025
Q3 		– Sell
-3,273
Closed -$271K – 412
2025
Q2 		$271K Buy
3,273
+159
+5% +$12.7K 0.01% 307
2025
Q1 		$253K Sell
3,114
-3,288
-51% -$294K 0.02% 285
2024
Q4 		$577K Sell
6,402
-1,248
-16% -$121K 0.03% 182
2024
Q3 		$756K Sell
7,650
-413
-5% -$40.6K 0.04% 154
2024
Q2 		$748K Sell
8,063
-3,105
-28% -$278K 0.05% 145
2024
Q1 		$1.06M Buy
11,168
+2,956
+36% +$274K 0.07% 113
2023
Q4 		$733K Buy
8,212
+295
+4% +$21.9K 0.05% 130
2023
Q3 		$578K Sell
7,917
-252
-3% -$20.1K 0.05% 145
2023
Q2 		$680K Buy
8,169
+34
+0.4% +$2.84K 0.06% 133
2023
Q1 		$620K Sell
8,135
-1,385
-15% -$115K 0.06% 136
2022
Q4 		$1.07M Buy
9,520
+654
+7% +$52.9K 0.11% 74
2022
Q3 		$703K Sell
8,866
-274
-3% -$23.1K 0.08% 112
2022
Q2 		$679K Sell
9,140
-678
-7% -$50.9K 0.07% 116
2022
Q1 		$882K Buy
9,818
+298
+3% +$27.5K 0.08% 86
2021
Q4 		$1.07M Sell
9,520
-726
-7% -$87.6K 0.11% 74
2021
Q3 		$1.29M Sell
10,246
-1,876
-15% -$242K 0.14% 67
2021
Q2 		$1.52M Buy
12,122
+3,893
+47% +$512K 0.17% 63
2021
Q1 		$1.12M Buy
8,229
+4,220
+105% +$632K 0.16% 61
2020
Q4 		$594K Buy
+4,009
New +$513K 0.09% 77

Other funds holding XBI

PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Annex Advisory Services
Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return
MIRAE ASSET SECURITIES (USA) INC.
MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.72% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return
Parkway Wealth Management
Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return
Weatherly Asset Management
Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return
L. Roy Papp & Associates
L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return
Madrona Financial Services
Madrona Financial Services Everett, Washington $646M AUM 23.24% 1-Year Est. Return
Royal Fund Management
Royal Fund Management Lady Lake, Florida $1.26B AUM 23.83% 1-Year Est. Return
Edge Wealth Management
Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

McAdam LLC's XBI Position: Q3 2026 in Review

McAdam LLC increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.63% in Q3 2026, buying an estimated $1.58K and bringing the position to 1,595 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #432.

McAdam LLC first reported a position in XBI in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.52M in Q2 2021. 288 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • McAdam LLC held 1,595 shares of State Street SPDR S&P Biotech ETF worth $252K as of Q3 2026.
  • McAdam LLC bought 10 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $1.58K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of McAdam LLC's portfolio in Q3 2026, its #432 holding.
  • McAdam LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 22 quarters since.
  • McAdam LLC's State Street SPDR S&P Biotech ETF position peaked at $1.52M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.